Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study observed that among Nepalese women with polycystic ovarian syndrome, menstrual irregularity was the most common symptom, and many had hormonal imbalances potentially increasing risks of cardiovascular disease and type 2 diabetes.

This study found that lifestyle interventions, along with regular medication, improved the quality of life for women with PCOS.

This review discusses the complexities and co-morbidities associated with polycystic ovary syndrome, including its impact on metabolic and psychological health, and reports no new clinical results.

This review highlights the increased need for awareness about Polycystic Ovarian Syndrome (PCOS) and suggests that more research is necessary to understand its management through lifestyle modifications.

This study found that discoid lupus erythematous was the most common type of primary cicatricial alopecia, predominantly affecting middle-aged women.

This review discusses polycystic ovarian syndrome, highlighting its symptoms, potential causes, and treatment options, but reports no new clinical results.

This study found that the SUCCESS education programme did not increase the step count at three months for women with PCOS, highlighting the need for further evaluation over a longer duration.

This study demonstrated that incorporating PDA@Ag nanoparticles into a cationic guar gum hydrogel significantly enhanced photothermal conversion efficiency, achieving superior antibacterial efficacy both in vitro and in vivo, advancing the potential of PDA as a photothermal antibacterial agent.

In this study, researchers found that hepatitis C virus infection is a significant risk factor for sporadic porphyria cutanea tarda, suggesting familial cases might be more prevalent in areas with low hepatitis C infection rates.

This article describes erosive pustular dermatosis of the scalp, emphasizing its chronic nature, potential complications, and the lack of specific diagnostic findings, but reports no new clinical results.

This review discusses the varying prevalence, symptoms, and potential genetic factors associated with Polycystic Ovary Syndrome in different populations, including its significant health impacts, and reports no new data on India's prevalence.

This review identified and evaluated polycystic ovary syndrome models of care, finding that only three fully aligned with international guidelines and generally received positive feedback on satisfaction; just one showed an impact on patients' BMI.

This case report highlights an 11-year-old girl with dermatopathia pigmentosa reticularis, identifying associated Salzmann's nodular degeneration of the cornea and emphasizing the need for a multidisciplinary management approach.

This study found that cortisone reductase deficiency is caused by inactivating mutations in the H6PD gene, affecting cortisol metabolism by preventing 11β-HSD1 enzyme function.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

This paper addresses diagnostic criteria and treatment options for polycystic ovary syndrome, emphasizing lifestyle changes and combination oral contraceptives as primary management strategies, but it reports no new clinical results.

This study emphasizes the importance of regular dental check-ups for patients undergoing systemic treatments for psoriatic disease, as it helps prevent oral complications associated with these medications. It recommends collaboration between dermatologists and oral health specialists to effectively manage and communicate these risks.

This review explores the psychosocial impact of PCOS symptoms on health-related quality of life, emphasizing the need for multidisciplinary care and individual perspectives, but reports no new research findings.

This study found that 19.5% of young girls screened using the Rotterdam criteria were diagnosed with polycystic ovarian syndrome, highlighting the importance of early screening and intervention.

This article reports on a patient case of Cronkhite-Canada syndrome, detailing symptoms and diagnostic findings, and reviews the syndrome's characteristics without presenting new clinical data.

This study observed that among women with polycystic ovary syndrome, those with the most severe phenotype showed the highest levels of metabolic disturbances, indicating the need for metabolic screening in these cases.

This study estimates the total cost of evaluating and treating polycystic ovary syndrome in reproductive-aged women in the United States to be $4.36 billion, suggesting more liberal screening could be beneficial.

This study found that DPCP immunotherapy effectively treats alopecia areata, identifying factors that influence treatment response and patient satisfaction, which may aid in standardizing the treatment for improved outcomes.

This article reviews the complications and health risks associated with polycystic ovary syndrome and reports no new clinical findings.

This study revealed significant signals of drug-related cognitive disorders in several medications that lack relevant FDA label warnings, suggesting a need for increased clinical awareness and potential label updates.

This review covers the diagnosis, complications, and management strategies for Polycystic Ovarian Disease, reporting no new clinical results and highlighting the potential of personalized medicine.

Obesity is common in PCOS patients and early treatment is important for their heart and metabolic health.

This article reviews neuroendocrine abnormalities in polycystic ovarian syndrome and reports no new findings, highlighting areas such as the hypothalamus-pituitary axis and genetic basis.

In this study, researchers used EHR data from two large PCORnet networks to identify a range of long COVID diagnoses, highlighting varying post-acute risks across populations in NYC and Florida.